Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 10.72
+0.02 (0.19%)
Sep 2, 2026, 5:29 PM CET
Vicore Pharma Holding AB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vicore Pharma Holding AB stock has a consensus rating of "Strong Buy" and an average price target of kr 29.25. The average 1-year stock price forecast is 172.85% higher than the current stock price, while the lowest is kr 15.00 (+39.93%) and the highest is kr 38.00 (+254.48%).
Price Target: kr 29.25 (+172.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vicore Pharma Holding AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates kr 38.00 | Buy | Reiterates | kr 38.00 | +254.48% | Aug 21, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates kr 33.00 | Buy | Initiates | kr 33.00 | +207.84% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
9.78M
from 3.82M
Increased by 156.17%
Revenue Next Year
59.54M
from 9.78M
Increased by 508.89%
EPS This Year
-1.96
from -1.99
EPS Next Year
-1.47
from -1.96
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.